STML - Stemline Therapeutics Inc.
Previous close
11.83
0 0%
Share volume: 0
Last Updated: Tue 09 Jun 2020 06:00:00 AM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
$11.83
0.00
0.00%
Summary score
22%
Profitability
21%
Dept financing
5%
Liquidity
45%
Performance
22%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-23.59%
Return on assets
-18.78%
Return on sales
-2293.09%
Return on invested capital
-398.08%
Total debt ratio
18.22%
Debt ratio change over timeo
-0.94%
Current Ratio
5.4%
Quick Ratio
6.71%
Cash Position Ratio
1.02%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.61%
Return on assets
-11.02%
Return on sales
-162.97%
Return on invested capital
80.66%
Total debt ratio
14.69%
Debt ratio change over timeo
-0.83%
Current Ratio
7.22%
Quick Ratio
7.13%
Cash Position Ratio
0.93%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.42%
Return on assets
-12.81%
Return on sales
-246.3%
Return on invested capital
100.36%
Total debt ratio
13.46%
Debt ratio change over time
-0.84%
Current Ratio
7.43%
Quick Ratio
7.37%
Cash Position Ratio
1.28%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-107.71%
Return on assets
-105.85%
Return on sales
790.07%
Return on invested capital
481.12%
Total debt ratio
-93.6%
Debt ratio change over time
-0.94%
Current Ratio
1.33%
Quick Ratio
7.14%
Cash Position Ratio
-0.99%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | STML | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -23.59% | -40.8% | -11.36% | -12.25% |
| Return on assets | -18.78% | -19.78% | -8.97% | -9.49% |
| Return on sales | -2293.09% | -5539.23% | 0% | -349.39% |
| Return on invested capital | -398.08% | 342.85% | -123.82% | -117.39% |
| Profitability | 0% | 25% | 75% | 0% |
| Total debt ratio | 18.22% | 121.38% | 25.26% | 26.21% |
| Debt ratio change over time | -0.94% | -0.12% | -1.11% | -1.45% |
| Dept financing | 4% | 50% | 5% | 5% |
| Current Ratio | 7.22% | 8.43% | 6.41% | 5.11% |
| Quick Ratio | 7.13% | 0% | 0% | 4.79% |
| Cash Position Ratio | 0.93% | 8.13% | 3.15% | 1.72% |
| Liquididy | 36% | 48% | 25% | 59% |
| Short-term ratios | STML | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -12.61% | -135.01% | -20.23% | -17.62% |
| Return on assets | -11.02% | -15.63% | -15.18% | -9.31% |
| Return on sales | -162.97% | 0% | 0% | -398.97% |
| Return on invested capital | 80.66% | 435.95% | 248.95% | -45.1% |
| Profitability | 30% | 25% | 39% | 25% |
| Total debt ratio | 14.69% | 74.66% | 29.16% | 48.64% |
| Debt ratio change over time | -0.83% | -0.82% | -1.48% | -2.29% |
| Dept financing | 5% | 50% | 10% | 16% |
| Current Ratio | 7.22% | 8.43% | 6.41% | 5.11% |
| Quick Ratio | 7.13% | 0% | 0% | 4.79% |
| Cash Position Ratio | 0.93% | 8.13% | 3.15% | 1.72% |
| Liquididy | 49% | 50% | 29% | 37% |